BNP Paribas Financial Markets’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$840K Buy
109,477
+70,505
+181% +$483K ﹤0.01% 3262
2025
Q4
$77.2K Sell
38,972
-16,033
-29% -$36.3K ﹤0.01% 4482
2025
Q3
$135K Buy
55,005
+22,870
+71% +$58.9K ﹤0.01% 4179
2025
Q2
$84.8K Buy
32,135
+14,643
+84% +$39.4K ﹤0.01% 4071
2025
Q1
$52.7K Sell
17,492
-17,496
-50% -$53K ﹤0.01% 4276
2024
Q4
$89.6K Buy
+34,988
New +$146K ﹤0.01% 4193
2022
Q4
Sell
-148,282
Closed -$737K 4299
2022
Q3
$737K Buy
+148,282
New +$676K ﹤0.01% 2704
2021
Q1
Sell
-6,256
Closed -$83.4K 4066
2020
Q4
$83.4K Sell
6,256
-975
-13% -$9.38K ﹤0.01% 3303
2020
Q3
$50.1K Buy
7,231
+6,070
+523% +$60.5K ﹤0.01% 3471
2020
Q2
$14.3K Buy
1,161
+1,077
+1,282% +$6.08K ﹤0.01% 3548
2020
Q1
$242 Sell
84
-151
-64% -$756 ﹤0.01% 4174
2019
Q4
$891 Sell
235
-3,071
-93% -$5.23K ﹤0.01% 4231
2019
Q3
$4.03K Hold
3,306
﹤0.01% 4296
2019
Q2
$3.37K Sell
3,306
-2,742
-45% -$3.16K ﹤0.01% 4283
2019
Q1
$9.56K Buy
6,048
+3,252
+116% +$4.08K ﹤0.01% 4028
2018
Q4
$3.24K Buy
2,796
+1,783
+176% +$4.08K ﹤0.01% 3710
2018
Q3
$3.75K Hold
1,013
﹤0.01% 4148
2018
Q2
$3.1K Sell
1,013
-4,971
-83% -$18.4K ﹤0.01% 4201
2018
Q1
$23.3K Buy
5,984
+113
+2% +$495 ﹤0.01% 3887
2017
Q4
$26.4K Buy
5,871
+2,832
+93% +$13.4K ﹤0.01% 3910
2017
Q3
$16.7K Sell
3,039
-176
-5% -$1.08K ﹤0.01% 3685
2017
Q2
$24.4K Buy
3,215
+2,736
+571% +$11.8K ﹤0.01% 3548
2017
Q1
$1.7K Sell
479
-134
-22% -$662 ﹤0.01% 3577
2016
Q4
$3.51K Sell
613
-881
-59% -$5.88K ﹤0.01% 3817
2016
Q3
$11.6K Sell
1,494
-12
-0.8% -$90 ﹤0.01% 3124
2016
Q2
$9.37K Buy
1,506
+1,446
+2,410% +$11.2K ﹤0.01% 2942
2016
Q1
$493 Sell
60
-1,154
-95% -$10.9K ﹤0.01% 2562
2015
Q4
$21K Sell
1,214
-21
-2% -$312 ﹤0.01% 3274
2015
Q3
$14.2K Buy
+1,235
New +$27K ﹤0.01% 3380

Other funds holding IBRX